About Conference
Conference Series LLC Ltd takes a great privilege to welcome you to the “World Congress on Genetic Research and Advanced Techniques" going to be held during May 18-19, 2022 in London, UK. "Euro Genetic Engineering 2022"hosted and organized by Conference Series LLC LTD provides an international forum for the exchange of information in a wide arena of branches of Genetic Engineering. The theme of the Conference is “Exploring Current Challenges in Genetic Engineering” This theme enables participants to develop their insight into their own research field while expanding their perspectives, providing sound knowledge to highly eminent professionals and young researchers.
“World Congress on Genetic Research and Advanced Techniques" aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Genetic Engineering and Genetic Technology. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of "Euro Genetic Engineering 2022".
Scientific Sessions
Scientific Sessions
Genetic Engineering, also called recombinant DNA technology, involves the group of techniques used to cut up and join together genetic material, especially DNA from different biological species, and to introduce the resulting hybrid DNA into an organism in order to form new combinations of heritable genetic material. Genetic engineering has been applied in numerous fields including research, medicine, industrial biotechnology and agriculture. Many more new discoveries are invented in the Genetic Research. But the few Recent Discoveries in
Genetic Engineering,
1. GM Mosquito Progeny Not Dying in Brazil: Study:
2. Timing and Order of Molecular Events Recorded in Live Cells’ DNA
3. FDA Lifts Import Restrictions on Genetically Engineered Salmon
4. Gene Drive–Equipped Mosquitoes Released into Lab Environment
5. Better Base Editing in Plants
6. Info graphic: Plant Genome Editors Get A New Tool
7. Opinion: GE Crops Are Seen Through a Warped Len
Crops:Genetically modified crops (GM crops) are plants used in agriculture, the DNA of which has been modified using genetic engineering methods. In most cases, the aim is to introduce a new trait to the plant which does not occur naturally in the species. Examples in food crops include resistance to certain pests, diseases, environmental conditions, reduction of spoilage, resistance to chemical treatments (e.g. resistance to a herbicide), or improving the nutrient profile of the crop. Examples in non-food crops include production of pharmaceutical agents, biofuels, and other industrially useful goods, as well as for bioremediation.
Food: Genetically modified foods (GM foods), also known as genetically engineered foods (GE foods), or bioengineered foods are foods produced from organisms that have had changes introduced into their DNA using the methods of genetic engineering. Genetic engineering techniques allow for the introduction of new traits as well as greater control over traits when compared to previous methods, such as selective breeding and mutation breeding.
A gene mutation is a permanent alteration in the DNA sequence that makes up a gene, such that the sequence differs from what is found in most people. Mutations range in size; they can affect anywhere from a single DNA building block (base pair) to a large segment of a chromosome that includes multiple genes. Mutation in the DNA of a body cell of a multicellular organism (somatic mutation) may be transmitted to descendant cells by DNA replication and hence result in a sector or patch of cells having abnormal function, an example being cancer.
Gene Therapy: Human DNA is estimated to have approximately 12 million single nucleotide polymorphisms (SNPs) and thousands of copy number variants (CNVs), most of which are not harmful. However, genetic disorders do sometimes occur as a result of mutations that alter or inhibit protein function.
Gene therapy focuses on correcting these mutated or defective genes by way of the following techniques:
-
Random insertion of a normal gene into the genome (most common technique)
-
Replacement of the abnormal gene with a normal one
-
Repair of the abnormal gene
-
Altering regulation of a particular gene.
IVF: The in vitro fertilization (IVF) "miracle" of the late 1970s occurred five years before the polymerase chain reaction revolutionized the field of genetics, 18 years before the first bacterial genome was sequenced, and 26 years before completion of the human genome sequence. Stem Cell Therapy: Beyond gene therapy, another issue of much debate relates to the use of stem cells.
These cells can be divided into two broad classes: embryonic and adult. Both classes are currently being explored for possible therapeutic applications.
Molecular cloning: It is a set of experimental methods in molecular biology that are used to assemble recombinant DNA molecules and to direct their replication within host organisms. The use of the word cloning refers to the fact that the method involves the replication of one molecule to produce a population of cells with identical DNA molecules. Molecular cloning generally uses DNA sequences from two different organisms: the species that is the source of the DNA to be cloned, and the species that will serve as the living host for replication of the recombinant DNA.
Gene Delivery
: Gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells. Genetic material must reach the nucleus of the host cell to induce gene expression. Successful gene delivery requires the foreign genetic material to remain stable within the host cell and can either integrate into the genome or replicate independently of it.
A genetically modified organism (GMO) is any organism whose genetic material has been altered using genetic engineering techniques. A wide variety of organisms have been genetically modified (GM), from animals to plants and microorganisms. People have been altering the genomes of plants and animals for many years using traditional breeding techniques. Agricultural plants are one of the most frequently cited examples of genetically modified organisms (GMOs). Some benefits of genetic engineering in agriculture are increased crop yields, reduced costs for food or drug production, reduced need for pesticides, enhanced nutrient composition and food quality, resistance to pests and disease, greater food security, and medical benefits to the world's growing population.
Clinical genetics involves the study, counselling and treatment of individuals and families with heritable disorders and disease predisposition. Diagnostic tools include standard ontologies for describing dysmorphology and traits, pedigree analysis, disease locus mapping by linkage or homozygosis, karyotyping, genome sequencing and genotyping.
DNA fingerprinting or DNA profiling is a method used to identify an individual from a sample of DNA by looking at unique patterns in their DNA. DNA profiling is a forensic technique in criminal investigations, comparing criminal suspects' profiles to DNA evidence so as to assess the likelihood of their involvement in the crime.
CRISPR is a type of gene-editing technology that lets scientists more rapidly and accurately 'cut' and 'paste' genes into DNA. It is based on a targeted DNA-destroying defense system originally found in certain prokaryotes. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats, a term that describes a family of nucleic acid sequences that were discovered in archea and bacteria in the 1990s containing copies of virus genes. This ability to identify specific DNA sequences with precision and break them apart was quickly recognized as a perfect tool for editing genes.
Market Analysis
Market Analysis
Genetic engineering is the procedure of using recombinant DNA (rDNA) technology to modify the genetic makeup of an organism. Conventionally, humans have influenced genomes indirectly by controlling breeding and selecting offspring with preferred traits. Genetic engineering involves the direct management of one or more genes. Most often, a gene from another species is added to an organism's genome to give it a desired phenotype.
Scope & Importance:
Genetic Engineering is a significant tool for scientists. Genes and other genetic evidence from a wide range of organisms are converted into bacteria, creating genetically modified bacteria in the procedure. The introduction of new DNA does not require the usage of classical genetic methods; however traditional breeding methods are typically used for the proliferation of recombinant organisms. An organism that is produced through the introduction of recombinant DNA is known to be a genetically modified organism. The first organisms genetically engineered were bacteria in 1973 and then mice in 1974.
Genetic Engineering is getting importance because of its use in different arenas. In medicine Genetic Engineering has been used to mass-produce insulin, human growth hormones, follistim (for treating infertility), human albumin, monoclonal antibodies, antihemophilic factors, vaccines and many other drugs.
Global Gene Editing Market:
Gene Editing Market size valued at USD 3.8 billion in 2019 and is expected to witness 14.9% CAGR from 2020 to 2026. Increasing advancements in Gene Editing Technologies are anticipated to boost the market demand.
Why to attend:
Growing awareness regarding availability of genetically modified crops and animals will have positive impact on the overall market revenue. Growing utilization of synthetic genes in incorporating newer biosynthetic pathway in microorganisms to manufacture biologics will escalate the market growth.
Scientific communities are considering gene editing tools such as CRISPR to potentially disrupt the SARS-CoV-2 genome, the virus that causes COVID-19.
This is anticipated to create growth opportunities for the businesses to invest in the gene editing market. In June 2020, Stanford University developed gene editing tool that destroys COVID-19 inside human cells. The tool is called PAC-MAN (Prophylactic Antiviral CRISPR in human cells). Development of such new and innovative gene editing approaches will fuel the market expansion.
Funding:
Improved funding for genetic research in developed regions including North America will drive the gene editing industry growth. The U.S. government capatalizes various research programs that facilitate the process of drug discovery for several rare genetic diseases. The National Institutes of Health (NIH), a principal agency of the U.S. government is accountable for research in genetics and biomedical and grants billions of dollars in funding. Research accomplishments for drug discovery increase the preference for gene editing performances. Also, recently developed remedies and drugs used in treatment of genetic diseases have reduced the mortality rates that will positively impact the industry size. The CRISPR-Cas9 section will spectate more than 15% growth rate during the period. Rising demand for CRISPR-Cas9 in varying the genome of organisms to develop commercially achievable products will accelerate the market demand. Also, CRISPR technology is simple, easy to use, and inexpensive unlike the other gene editing techniques such as TALENs, thus, increasing its adoption rate. Key market performers such as Thermo Fisher Scientific, Caribou Biosciences, Takara Bio, are focusing on R&D activities for adding inventions in the CRISPR-Cas9 technology that has elevated inclination in research processes.
The pharma and biotech companies segment controlled around 46% gene editing market share in 2019 owing to grow focus of biotech companies on developing advanced gene editing technologies. Technological advancements in gene editing enable market performers to progress advanced technologies that are effective enough in treatment of a specific genetic disease as compared to the predictable therapies.
Past Conference Report
“Euro Genetic Engineering 2020” which was held in Tokyo, Japan during December 14-15, 2020. Euro Genetic Engineering 2020 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Genetic Research. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world, Genetic Conferences.
The conference aimed a parallel rail with theme “Exploring Current Challenges in Genetic Engineering”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Genetically Modified Crops and Food, Genetic Change and Mutations, Molecular Cloning and Gene Delivery, Genetically Modified Organisms
The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honourable Guests and members of the Keynote forum.
"New Frontiers on Genetic Research & Advanced Techniques" December 14-15, 2020 would not have reached the pinnacle if not with the support of International, multi-professional steering committee and coordination of the Journal of Biotechnology & Biomaterials, Journal of Molecular and Genetic Medicine and Journal of Bioremediation & Biodegradation; hence, we express our deep sense of gratitude. After the successful completion of Euro Genetic Engineering 2020. We are glad to announce our next upcoming conference which is going to be held during May 18-19, 2022 at London UK. Mark your calendars; we are hoping to see you soon!
Let us meet again @."Euro Genetic Engineering 2022"
